News

Filter

Current filters:

ImbruvicaPharmacyclics

1 to 9 of 95987 results

Lundbeck launches Northera in USA

Lundbeck launches Northera in USA

02-09-2014

Danish CNS specialist Lundbeck said today that Northera (droxidopa) capsules for oral use are now available…

Chelsea TherapeuticsLundbeckMarkets & MarketingNeurologicalNortheraPharmaceuticalUSA

Allergan’s Ozurdex approved for DME in Europe

Allergan’s Ozurdex approved for DME in Europe

02-09-2014

Allergan revealed today that the European Commission has extended the marketing authorization for Ozurdex…

AllerganEuropeOphthalmicsOzurdexPharmaceuticalRegulation

Australia participating in EU DCP for evaluation of generic drugs

Australia participating in EU DCP for evaluation of generic drugs

02-09-2014

Under the auspices of the International Generic Drug Regulators Pilot , Australia’s Therapeutic Goods…

AustraliaGenericsRegulation

Australian medical bodies advocate for the government's Medical Research Future Fund

Australian medical bodies advocate for the government's Medical Research Future Fund

02-09-2014

Australian medical bodies are collaborating to advocate for the Medical Research Future Fund (MRFF) proposed…

AustraliaBiotechnologyFinancialMRFF Action GroupPolitics

Drew Young appointed senior vice president of neurology and immunology at EMD Serono

Drew Young appointed senior vice president of neurology and immunology at EMD Serono

02-09-2014

EMD Serono, a subsidiary of Germany's Merck KGaA, has appointed Drew Young as senior vice president of…

BoardroomEMD Serono

Exelixis says cabozantinib failed in Ph III prostate cancer trial

Exelixis says cabozantinib failed in Ph III prostate cancer trial

02-09-2014

US biotech firm Exelixis has posted disappointing top-line results from the final analysis of COMET-1,…

BiotechnologycabozantinibExelixisOncologyResearchSwedish Orphan Biovitrum

1 to 9 of 95987 results

Company Spotlight

ImmunoGen

ImmunoGen

Back to top